<DOC>
	<DOCNO>NCT02430012</DOCNO>
	<brief_summary>The investigator identify underuse secondary prevention medication discharge patient underwent coronary artery bypass grafting ( CABG ) China . The aim study develop series quality improvement strategy focus secondary prevention medication patient underwent CABG , evaluate effectiveness safety via hospital-level cluster randomize clinical trial . The investigator establish network 60 hospital participate Chinese Cardiovascular Surgery Registry submit 50 CABG surgery already . The participate site divide intervention control group 1:1 ratio . The intervention group undertake intervention quality improvement strategy , control group maintain routine practice pattern . All hospital consecutively enroll submit data CABG enrollment period , estimate 6 month . The prescribing rate angiotensin convert enzyme inhibitor ( ACEI ) , angiotensin receptor blocker ( ARB ) , beta-blockers , statin aspirin compare 2 group .</brief_summary>
	<brief_title>Quality Measurement Improvement Study Surgical Coronary Revascularization : Secondary Prevention</brief_title>
	<detailed_description>The investigator identify underuse secondary prevention medication discharge patient underwent coronary artery bypass grafting ( CABG ) China . The aim study develop series quality improvement strategy focus secondary prevention medication patient underwent CABG , evaluate effectiveness safety via hospital-level cluster randomize clinical trial . The investigator establish network 60 hospital participate Chinese Cardiovascular Surgery Registry submit 50 CABG surgery already . The participate site divide intervention control group 1:1 ratio . The intervention group undertake intervention quality improvement strategy , control group maintain routine practice pattern . All hospital consecutively enroll submit data CABG enrollment period estimate 6 month . The prescription rate ACEI , ARB , beta-blockers , statin aspirin compare 2 group . Before enrollment period , investigator develop series quality improvement strategy focus secondary prevention medication patient underwent CABG , include train guideline secondary prevention , determine improvement goal participate site , intervention tool ( workflow poster card , checklist inform use secondary prevention medication ) periodical quality feedback report . In enrollment period , participate hospital divide intervention control group 1:1 ratio use minimization allocation . The investigator collect data prescription rate central medical record abstraction , case report form submit participate site checklist submit intervention group .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Patients underwent CABG enrollment period participate site Patients die hospitalization Patients withdraw hospital doctor ' recommendation Patients transfer medical care institution without discharge prescription</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>coronary artery bypass grafting</keyword>
	<keyword>quality improvement</keyword>
	<keyword>secondary prevention</keyword>
</DOC>